1Clinical and Laboratory Standards Institute. Abbreviatedidentification of bacteria and yeast : approved guideline[S]. M35-A2, CLSI.
2Hsueh PH, Chen WH , Luh KT. Relationshipsbetween antimicrobial use and antimicrobial resistancein Gram-negative bacteria causing nosocomial infec-tions from 1991-2003 at a university hospital in Taiwan[J]. Int J Antimicrob Agents, 2005 , 26(6〉: 463-472.
3Xu X, Wu S, Ye X, et al. Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1. Antimicrob Agents Chemother, 2007, 51: 4105-4110.
4Tran JH, Jacoby GA, Hooper DC. Interaction of the plasmidencoded quinolone resistance protein Qnr with Escherichia cob DNA gyrase. Antimicrob Agents Chemother, 2005,49 : 118-125.
5Tran JH, Jacoby GA, Hooper DC. Interaction of the plasmidencoded quinolone resistance protein QnrA with Escherichia coil topoisomerase IV. Antimicrob Agents Chemother, 2005, 49: 3050-3052.
6Hooper DC. Mechanisms of action and resistance of older and newer fluoroquinolones. Clin Infect Dis, 2000, 31 : S24-S28.
7Martinez-Martinez L, Pascual A, Jacoby GA. Quinolone resistance from a transferable plasmid. Lancet, 1998, 351 : 797- 799.
8Hata M, Suzuki M, Matsumoto M, et al. Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b. Antimicrob Agents Chemother, 2005, 49: 801-803.
9Jacoby GA, Walsh KE, Mills DM, et al. qnrB, another plasmidmediated gene for quinolone resistance. Antimicrob Agents Chemother, 2006, 50 : 1178-1182.
10Robiesek A, Strahilevitz J, Jacoby GA, et al. Fluoroquinolone modifying enzyme: a new adaptation of a common aminoglycoside acetyhransferase. Nat Med, 2006, 12 : 83-88.
3Coker C, Poore CA, Li X, et al. Pathogenesis of Pro- teus mirabilis urinary tract infection[J]. Microbes In- fect, 2000,2 : 1497-1505.
4Alamuri P, Mobley HL. A novel autotransporter of uropathogenic Proteus mirabilis is both a cytotoxin and an agglutinin[J]. Mol Microbiol, 2008,68 : 997-1017.
5Pearson MM, Sebaihia M, Churcher C, et al. Com- plete genome sequence of uropathogenic Proteus mira- bilis, a master of both adherence and motility[J]. J Bacteriol,2008,190:4027-4037.
6Rozalski A, Si- dorczyk Z, Kotelko K. Potential virulence factors of Proteus bacilli[J]. Microbiol Mol Biol Rev, 1997,61: 65-89.
7Khajuria A, Praharaj AK, Kumar M, et al. Emer- gence of VIM- 6 metallo-beta-lactamase- producingAlcaligenes faecalis clinical isolates in a hospital in In- dia[J]. J Infect Dev Ctries. 2013 Jun 15 7 (6).. 494-496.
8Winn W Jr, Allen S, Janda W, et al. The Non-fer- mentative Gram-negative bacilli, Chapter 7 [J]. In.. Koneman's Color Atlas and Textbook of Diagnostic Mi- crobiology, 6th ed, 2006, Baltimore: Lippincott Wil- liams and Wilkins Company 303-391.
9Sawant AC, Srivatsa SS, Castro LJ. Alcaligenes xy- losoxidansEndocarditis of a Prosthetic Valve and Pace- maker in a 62--Year--Old Woman[J]. Tex Heart Inst J. 201340(1) :95-8.
10Dainel A,Thierry N,Marie FL,et al. Novel genen- tic structure associated with an extended-spectrum 13- lactamase blaVEB gene in a Providencia stuartii clini- cal isolate from Algeria[J]. J Antimicrob Agents Che- mother,2005,49(8) :3590-3592.
